Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-09-14

Clinical Trial Update: Stem Cell Study for Patients With Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 stem cell trial for heart failure/ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Losordo, Douglas, M.D. | Conditions: Myocardial Ischemia, Congestive Heart Failure | Phase 2 | Status: WITHDRAWN